Linda Y. Wu

724 total citations
11 papers, 135 citations indexed

About

Linda Y. Wu is a scholar working on Epidemiology, Neurology and Oncology. According to data from OpenAlex, Linda Y. Wu has authored 11 papers receiving a total of 135 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 5 papers in Neurology and 4 papers in Oncology. Recurrent topics in Linda Y. Wu's work include Neuroblastoma Research and Treatments (5 papers), Neuroendocrine Tumor Research Advances (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Linda Y. Wu is often cited by papers focused on Neuroblastoma Research and Treatments (5 papers), Neuroendocrine Tumor Research Advances (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Linda Y. Wu collaborates with scholars based in United States, Canada and Taiwan. Linda Y. Wu's co-authors include Mark M. Souweidane, Melinda Wang, Ranjodh Singh, Uday Bhanu Maachani, Raymond Chuen‐Chung Chang, Diane Reidy‐Lagunes, Umberto Tosi, Nitya Raj, Benedict Law and Þorvarður R. Hálfdánarson and has published in prestigious journals such as Journal of Clinical Oncology, Journal of neurosurgery and Molecular Cancer Therapeutics.

In The Last Decade

Linda Y. Wu

10 papers receiving 132 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Linda Y. Wu United States	7	55	54	49	46	43	11	135
Shin‐Hyuk Kang South Korea	7	47 0.9×	36 0.7×	44 0.9×	24 0.5×	18 0.4×	21	173
Andrés Morales La Madrid Spain	7	46 0.8×	19 0.4×	53 1.1×	94 2.0×	36 0.8×	22	168
Melitta Kitzwoegerer Austria	6	40 0.7×	17 0.3×	38 0.8×	30 0.7×	25 0.6×	6	119
Georgios Solomou United Kingdom	7	32 0.6×	17 0.3×	45 0.9×	35 0.8×	18 0.4×	21	175
Omid Shah United States	6	33 0.6×	62 1.1×	53 1.1×	22 0.5×	7 0.2×	7	197
Mikaella Vouri United Kingdom	4	22 0.4×	57 1.1×	62 1.3×	26 0.6×	18 0.4×	8	219
Macarena I. de la Fuente United States	8	52 0.9×	27 0.5×	34 0.7×	122 2.7×	29 0.7×	13	180
Amy Vanko United States	7	19 0.3×	27 0.5×	46 0.9×	35 0.8×	23 0.5×	8	155
Alexey Gurevich United States	7	19 0.3×	44 0.8×	40 0.8×	13 0.3×	14 0.3×	12	160
Evangeline R. Jackson Australia	5	27 0.5×	25 0.5×	58 1.2×	75 1.6×	10 0.2×	7	124

Countries citing papers authored by Linda Y. Wu

Since Specialization

Citations

This map shows the geographic impact of Linda Y. Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linda Y. Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linda Y. Wu more than expected).

Fields of papers citing papers by Linda Y. Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linda Y. Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linda Y. Wu. The network helps show where Linda Y. Wu may publish in the future.

Co-authorship network of co-authors of Linda Y. Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Linda Y. Wu. A scholar is included among the top collaborators of Linda Y. Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linda Y. Wu. Linda Y. Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Wu, Linda Y., et al.. (2025). Revision of reverse total shoulder arthroplasty: a scoping review of indications for revision, and revision outcomes, complications, and rerevisions. Journal of Shoulder and Elbow Surgery. 34(11). 2645–2654.

Wu, Linda Y., Sarah Cappuyns, Sara Lewis, et al.. (2024). Impact of underlying liver disease on unresectable hepatocellular carcinoma treated with immune checkpoint inhibitors. PubMed. 2(1). 8–8. 6 indexed citations

Wu, Linda Y., Umut Özbek, Anuhya Gampa, et al.. (2022). Outcomes of beta blockers (BB) in hepatocellular carcinoma (HCC) treated with immune checkpoint inhibitors (ICIs).. Journal of Clinical Oncology. 40(4_suppl). 399–399. 2 indexed citations

Wu, Linda Y., et al.. (2022). Effect of immune checkpoint inhibitor (ICI) treatment in hepatocellular carcinoma (HCC) based on underlying liver disease.. Journal of Clinical Oncology. 40(4_suppl). 396–396. 1 indexed citations

Chan, David, Emily K. Bergsland, Jennifer A. Chan, et al.. (2021). Temozolomide in Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms: A Multicenter Retrospective Review. The Oncologist. 26(11). 950–955. 28 indexed citations

Wu, Linda Y., Nitya Raj, & Diane Reidy‐Lagunes. (2019). Exceptional Responses After Cessation of Therapy With Alkylating Agents for Pancreatic Neuroendocrine Tumors. Pancreas. 49(1). e14–e16. 2 indexed citations

Chan, David, Emily K. Bergsland, Jennifer A. Chan, et al.. (2019). Temozolomide in grade III neuroendocrine neoplasms (G3 NENs): A multicenter retrospective review.. Journal of Clinical Oncology. 37(4_suppl). 321–321. 8 indexed citations

Chang, Raymond Chuen‐Chung, Umberto Tosi, Linda Y. Wu, et al.. (2019). Combined targeting of PI3K and MEK effector pathways via CED for DIPG therapy. Neuro-Oncology Advances. 1(1). vdz004–vdz004. 14 indexed citations

Wang, Melinda, Umberto Tosi, Zhiping Zhou, et al.. (2017). A Murine Model for Quantitative, Real-Time Evaluation of Convection-Enhanced Delivery (RT-CED) Using an 18[F]-Positron Emitting, Fluorescent Derivative of Dasatinib. Molecular Cancer Therapeutics. 16(12). 2902–2912. 15 indexed citations

10.

Wu, Linda Y., Uday Bhanu Maachani, Ranjodh Singh, et al.. (2017). Dual Inhibition of PI3K/AKT and MEK/ERK Pathways Induces Synergistic Antitumor Effects in Diffuse Intrinsic Pontine Glioma Cells. Translational Oncology. 10(2). 221–228. 49 indexed citations

11.

Singh, Ranjodh, Melinda Wang, Linda Y. Wu, et al.. (2017). Volume of distribution and clearance of peptide-based nanofiber after convection-enhanced delivery. Journal of neurosurgery. 129(1). 10–18. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact